InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,902.40
(
0.17%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lax20m

Send PM Follow Ignore
Followers 16
Posts 2238
Boards Moderated 0
Alias Born 06/22/2010

lax20m

Re: nsomniyak post# 53128

Monday, 09/01/2014 2:40:18 PM

Monday, September 01, 2014 2:40:18 PM

Post# of 80490
Certainly can't hurt but totally agreed. SAEs may not have been fully reported by Novartis but gleevac has been used as the control arm in numerous studies. The safety profile still exceeds it's competition even reported by competitor studies. While it might not be good for Novartis from a legal perspective it doesn't translate to a windfall far ariad.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up